全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Comparison of Within-Subjects and Between-Subjects Designs in Studies with Discrete-Time Survival Outcomes

DOI: 10.4236/ojs.2017.72023, PP. 305-322

Keywords: Balaam’s Design, Crossover Design, Cost-Efficiency, Discrete-Time Survival Endpoint, Efficiency Measure, Parallel Group Design

Full-Text   Cite this paper   Add to My Lib

Abstract:

Crossover designs are well-known to have major advantages when comparing the effects of various non-curative treatments. We compare efficiencies of several crossover designs along with the Balaam’s design with that of a parallel group design pertaining to longitudinal studies where event time can only be measured in discrete time intervals. With equally sized sequences, the parallel group design results in the greater efficiency if the number of time periods is small. However, the crossover and Balaam’s designs tend to be more efficient as the study duration increases. The degree to which these designs add efficiency depends on the baseline hazard function and effect size. Additionally, we incorporate different cost considerations at the subject level when comparing the designs to determine the most cost-efficient design. Researchers might consider the crossover or Balaam’s design more efficient if the duration of the study is long enough, especially if the costs of applying the baseline treatment are higher.

References

[1]  Józwiak, K. and Moerbeek, M. (2012) Cost-Effective Designs for Trials with Discrete-Time Survival Endpoints. Computational Statistics and Data Analysis, 56, 2086-2096.
https://doi.org/10.1016/j.csda.2011.12.018
[2]  Józwiak, K. and Moerbeek, M. (2013) Optimal Treatment Allocation and Study Duration for Trials with Discrete-Time Survival Endpoints. Journal of Statistical Planning and Inference, 143, 971-982.
https://doi.org/10.1016/j.jspi.2012.11.006
[3]  Lindstrom, D., Sundberg-Petersson, I., Adami, J. and Tonnesen, H. (2010) Disappointment and Dropout Rate after Being Allocated to Control Group in a Smoking Cessation Trial. Contemporary Clinical Trials, 31, 22-26.
https://doi.org/10.1016/j.cct.2009.09.003
[4]  Jones, B. and Kenward, M.G. (2002) Design and Analysis of Cross-Over Trials. Chapman & Hall/CRC, Boca Raton.
[5]  Senn, S. (2002) Cross-Over Trials in Clinical Research. Willey, Chichester.
https://doi.org/10.1002/0470854596
[6]  Berger, M.P. and Wong, W.K. (2009) An Introduction to Optimal Designs for Social and Biomedical Research. Willey, Chichester.
https://doi.org/10.1002/9780470746912
[7]  Morel, J.G. and Neerchal, N.K. (2012) Sample Size Determination for Alternative Periods of Use Study Designs with Binary Responses. Journal of Biopharmaceutical Statistics, 22, 351-367.
https://doi.org/10.1080/10543406.2010.539082
[8]  Senn, S. (2006) Cross-Over Trials in Statistics in Medicine: The First “25” Years. Statistics in Medicine, 25, 3430-3442.
https://doi.org/10.1002/sim.2706
[9]  Bryant, J. and Wolmark, N. (2003) Letrozole after Tamoxifen for Breast Cancer— What Is the Price of Success? The New England Journal of Medicine, 349, 1855-1857.
https://doi.org/10.1056/NEJMe038167
[10]  France, L.A., Lewis, J.A. and Kay, R. (1991) The Analysis of Failure Time Data in Crossover Studies. Statistics in Medicine, 10, 1099-1113.
https://doi.org/10.1002/sim.4780100710
[11]  Cox, D.R. (1972) Regression Models and Life-Tables. Journal of the Royal Statistical Society, Series B, 34, 187-220.
[12]  Buyze, J. and Goetghebeur, E. (2013) Crossover Studies with Survival Outcomes. Statistical Methods in Medical Research, 22, 612-629.
https://doi.org/10.1177/0962280211402258
[13]  Cohlen, B., Velde, E., Kooij, R., Looman, C. and Habbema, J. (1998) Controlled Ovarian Hyperstimulation and Intrauterine Insemination for Treating Male Subfertility: A Controlled Study. Human Reproduction, 13, 1553-1558.
https://doi.org/10.1093/humrep/13.6.1553
[14]  Balaam, L. (1968) A Two Period Design with t2 Experimental Units. Biometrics, 24, 61-73.
https://doi.org/10.2307/2528460
[15]  Singer, J.D. and Willett, J.B. (2003) Applied Longitudinal Data Analysis. Modeling Change and Event Occurrence. Oxford University Press, Oxford.
https://doi.org/10.1093/acprof:oso/9780195152968.001.0001
[16]  McCullagh, R.M. and Nelder, J.A. (1989) Generalized Linear Models. Chapman and Hall, London.
[17]  Atkinson, A.C., Donev, A.N. and Tobias, R.D. (2007) Optimum Experimental Design, with SAS. Clarendon, Oxford.
[18]  Carriere, K. and Reinsel, G. (1992) Investigation of Dual-Balanced Crossover Designs for Two Treatments. Biometrics, 48, 1157-1164.
https://doi.org/10.2307/2532706
[19]  Safarkhani, M. and Moerbeek, M. (2014) The Influence of a Covariate on Optimal Designs in Longitudinal Studies with Discrete-Time Survival Endpoints. Computational Statistics & Data Analysis, 75, 217-226.
https://doi.org/10.1016/j.csda.2014.02.012

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133